EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the interplay of psychiatric symptoms, antipsychotic medications, side effects, employment status, and quality of life in Chronic Schizophrenia

Dan-Na Zhou, Xue Yang, Wen Wang, Wen-Qing Jin, Yi-Lang Tang, Zhi Zheng, Yanping Ren

BMC Psychiatry · 02.07.2024 · 24 (1)

DOI: 10.1186/s12888-024-05929-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Psychiatry, online erschienen am 02.07.2024. Verfasst von Dan-Na Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, National Clinical Research Center for Mental Disorders & National Center for Men…. Hauptthemen laut MEDLINE: Quality of Life, Schizophrenia, Antipsychotic Agents, Employment. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Science & Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Many factors contribute to quality of life (QoL) in patients with schizophrenia, yet limited research examined these factors in patients in China. This cross-sectional study explores subjective QoL and its associated factors in patients.

Methods

The QoL was assessed using the Schizophrenia Quality of Life Scale (SQLS). Clinical symptoms were evaluated using the Brief Psychiatric Rating Scale (BPRS) and seven factors were extracted. Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder Scale (GAD-7) were used to assess depression and anxiety. Cognitive impairment was assessed using the Ascertain Dementia 8 (AD8). The Treatment Emergent Symptom Scale (TESS) and Rating Scale for Extrapyramidal Side Effects (RSESE) were used to evaluate the side effects of medications.

Results

We recruited 270 patients (male:142,52.6%, mean age:41.9 ± 9.4 years). Positive correlations were observed between SQLS and its subdomains with the total score of BPRS, PHQ-9, GAD-7, AD8, TESS, and RSESE (all P < 0.005). Patients who were taking activating second-generation antipsychotics (SGAs) had lower scores on total SQLS, Motivation/ Energy domain of SQLS (SQLS-ME) as well as Symptoms/ Side effects domain of SQLS (SQLS-SS) compared to those taking non-activating SGAs (all P < 0.005). Multiple regression analysis showed that depressive/ anxiety symptoms and cognitive impairment had significant negative effects on QoL ( P ≤ 0.001), while activating SGAs had a positive effect ( P < 0.005). Blunted affect and unemployment were inversely associated with the motivation/energy domain ( P < 0.001).

Conclusion

Our findings emphasize the important role of depression/anxiety symptoms and cognitive impairment in the QoL of patients with chronic schizophrenia. Activating SGAs and employment may improve the QoL of these individuals.

Trial registration

This protocol was registered at chictr.org.cn (Identifier: ChiCTR2100043537).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeSchizophreniaAntipsychotic AgentsEmploymentHumansMaleFemaleCross-Sectional StudiesAdultMiddle AgedChinaSchizophrenic PsychologyChronic DiseaseCognitive DysfunctionAnxietyDepression

Stichwörter der Autor:innen

Antipsychotic medicationClinical symptomsQuality of lifeSchizophreniaSide effects

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Capital Medical University, Beijing, China.
  • Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.
  • The First Psychiatric Hospital of Harbin, Harbin, Heilongjiang Province, China.
  • Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, 30329, USA.
  • Mental Health Service Line, Atlanta VA Medical Center, Decatur, GA, 30033, USA.
  • Huai'an No. 3 People's Hospital, Huaian, Jiangsu Province, China. zhengzhi665588@163.com.

Förderung

  • Beijing Municipal Science & Technology Commission

Zitieren

APA

Zhou, D. N., Yang, X., Wang, W., Jin, W. Q., Tang, Y. L., Zheng, Z., & Ren, Y. (2024). Exploring the interplay of psychiatric symptoms, antipsychotic medications, side effects, employment status, and quality of life in Chronic Schizophrenia. BMC Psychiatry, 24(1). https://doi.org/10.1186/s12888-024-05929-3

Vancouver

Zhou DN, Yang X, Wang W, Jin WQ, Tang YL, Zheng Z, et al. Exploring the interplay of psychiatric symptoms, antipsychotic medications, side effects, employment status, and quality of life in Chronic Schizophrenia. BMC Psychiatry. 2024;24(1). doi:10.1186/s12888-024-05929-3

BibTeX
@article{Zhou2024,
  author = {Zhou, Dan-Na and Yang, Xue and Wang, Wen and Jin, Wen-Qing and Tang, Yi-Lang and Zheng, Zhi and Ren, Yanping},
  title = {Exploring the interplay of psychiatric symptoms, antipsychotic medications, side effects, employment status, and quality of life in Chronic Schizophrenia},
  journal = {BMC Psychiatry},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1186/s12888-024-05929-3}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche